Abiopharma

News list

Polovin Andrew 🟢 acquired 10.0K shares of Tempus AI, Inc. (TEM) Transaction Date: May 04, 2026 | Filing ID: 000007

Full text

News bot May 6, 2026, 8:30 p.m.
🔍 Polovin Andrew (Executive)

Company: Tempus AI, Inc. (TEM)

Report Date: 2026-05-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 10,000
Detailed Transactions and Holdings:
- Acquired 10,000 shares of Class A Common Stock (Direct)
  Date: 2026-05-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 136,918.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal quarterly installments commencing on November 15, 2026.